1. Ewing family tumors of the appendicular skeleton: a retrospective analysis of prognostic factors
- Author
-
Francesco Muratori, Filippo Frenos, Rodolfo Capanna, Domenico Andrea Campanacci, Lorenzo Foschi, Giovanni Beltrami, Annarita Palomba, Mauro Loi, Daniela Greto, Giuliana Roselli, Angela Tamburini, and Nicola Mondanelli
- Subjects
medicine.medical_specialty ,Adolescent ,Appendicular skeleton ,Poor responder ,Bone Neoplasms ,Sarcoma, Ewing ,Gastroenterology ,Metastasis ,Age ,Ewing ,Internal medicine ,Retrospective analysis ,Overall survival ,Tumor volume ,Humans ,Medicine ,Orthopedics and Sports Medicine ,Single institution ,Bone tumor ,Ewing sarcoma ,Combined Modality Therapy ,Prognosis ,Retrospective Studies ,Skeleton ,business.industry ,Sarcoma ,medicine.disease ,medicine.anatomical_structure ,Surgery ,business - Abstract
Authors retrospectively analyzed possible prognostic factors in a series of patients affected by Ewing sarcoma of extremities (eEWS) and treated over a 20-year period at a single institution. Between 1997 and 2017, 88 bone eEWS were treated at our institution. Staging, age, gender, tumoral volume, local treatment, surgical margins, post-ChT necrosis were investigated for prognostic correlation with overall survival (OS) and event-free survival (EFS). Median follow-up was 74 months (1–236). Staging of disease correlated with OS (81% vs 59%, p = 0.01) and not with EFS (68% vs 57%, p = 0.28) in localized vs metastatic eEWS at presentation. Age ≥ 14 years (p = 0.002) and volume ≥ 100 cm3 (p = 0.04) were significant negative prognostic factors. No difference was found in local treatment: OS was 76% vs 63% (p = 0.33), while EFS was 68% vs 49% (p = 0.06) after surgery alone or surgery + radiotherapy, respectively. Regarding surgical margins, OS was 76% vs 38% (p = 0.14), and EFS was 65% vs 33% (p = 0.14) in adequate vs not adequate, respectively. OS was 86% and 68% in good and poor responders, respectively (p = 0.13). In eEWS, metastatic disease at presentation, age > 14 years and tumoral volume > 100 cm3 are negative prognostic factors. Intensified adjuvant ChT can improve prognosis in poor responders and metastatic patients.
- Published
- 2021